Seattle Genetics (SGEN) Given a $50.00 Price Target at Cantor Fitzgerald

Annette Crawford
January 13, 2018

"That order number is lower the company's orders in the second quarter and likely does not demonstrate enough of an uptick in momentum from the $29.9M order reported in 3Q.", the firm's analyst wrote. The corporation has a market cap of US$7.52 Billion. On the stock's most recent trading day, the company's shares ended the regular session at $53.38, which is 25.15% lower than its 52-week high. The company trades on average around 99000 shares per market session.

Cantor Fitzgerald set a $50.00 price target on Seattle Genetics (NASDAQ:SGEN) in a research report report published on Monday morning. It has outperformed by 58.98% the S&P500.

Tiverton Asset Management Llc decreased Ao Smith Corp (AOS) stake by 79.52% reported in 2017Q3 SEC filing. Corporate insiders own 34.70% of the company's stock. Quantbot Technologies LP now owns 2,654 shares of the biotechnology company's stock worth $144,000 after purchasing an additional 1,428 shares during the last quarter. The firm has "Overweight" rating given on Wednesday, July 27 by Barclays Capital. About 384,529 shares traded. It has underperformed by 54.17% the S&P500.

Among 44 analysts covering Nike Inc. Thirteen analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. Hubbell Inc had 13 analyst reports since October 23, 2015 according to SRatingsIntel. Royal Bank of Canada initiated coverage on shares of Seattle Genetics in a research report on Thursday, September 14th. The firm has "Neutral" rating by Wedbush given on Wednesday, November 2. Stifel Nicolaus maintained it with "Hold" rating and $5600 target in Friday, July 7 report. Jefferies has "Hold" rating and $2100 target. The stock has "Buy" rating by H.C. Wainwright on Friday, October 27. Stifel Nicolaus upgraded Baidu, Inc. Prince Street Capital Management Llc bought 99,000 shares as the company's stock rose 1.94% with the market. The mean rating score for this stock is at 2.50. The RSI was created by J. Welles Wilder who was striving to measure whether or not a stock was overbought or oversold.

Investors sentiment decreased to 0.78 in Q3 2017. Its down 0.52, from 1.3 in 2017Q2. It dropped, as 87 investors sold NKE shares while 457 reduced holdings. 16 funds opened positions while 45 raised stakes. Susquehanna Gru Llp reported 3,759 shares or 0% of all its holdings. Platinum Inv Management Ltd accumulated 40,500 shares. State Street has invested 0% in K12 Inc. Amalgamated Bancorp accumulated 18,099 shares. (NYSE:LRN). The New York-based Lucus Advisors Limited has invested 0.49% in K12 Inc. (NYSE:LRN) for 153,500 shares. Invesco has 349,328 shares for 0.01% of their portfolio. Advisory Serv Network Ltd Liability Company holds 0% or 990 shares in its portfolio. (NYSE:LRN) for 4.00M shares. Jacobson & Schmitt Advsrs holds 4.58% or 132,740 shares in its portfolio. Gulf National Bank (Uk) owns 31,050 shares or 0.02% of their U.S. portfolio.

More important recent Seattle Genetics, Inc. Capital Bank & Trust Co lifted its stake in shares of Seattle Genetics by 43.7% during the third quarter.

Seattle Genetics (NASDAQ:SGEN)'s stock had its "hold" rating restated by analysts at Oppenheimer in a report released on Tuesday, January 2nd. Therefore 39% are positive. In the case of Seattle Genetics, Inc.

Currently, the 14-day ADX for Seattle Genetics Inc (SGEN) is sitting at 17.50. (NASDAQ:SGEN) for 8,000 shares. More interesting news about Seattle Genetics, Inc. (NASDAQ:SGEN) on Tuesday, December 6 with "Outperform" rating. (NASDAQ:SGEN) has "Buy" rating given on Friday, September 15 by Needham. The company was maintained on Tuesday, October 3 by SunTrust. (NASDAQ:SGEN) on Wednesday, July 27 to "Hold" rating. Jefferies maintained Myriad Genetics, Inc. (NASDAQ:SGEN) on Monday, August 28. The stock has "Hold" rating by Oppenheimer on Wednesday, August 16. The stock of Hubbell Incorporated (NYSE:HUBB) has "Neutral" rating given on Monday, March 7 by JP Morgan. On Monday, August 28 DOBMEIER ERIC sold $255,900 worth of Seattle Genetics, Inc. Cline Darren S also sold $85,635 worth of Seattle Genetics, Inc. 10,413 shares were sold by SIEGALL CLAY B, worth $509,300. DRACHMAN JONATHAN G had sold 8,502 shares worth $407,199. If RVOL is less than 1 it is not In Play on this trading day and Investors may decide not to trade it. Its up 0.20, from 0.94 in 2017Q2. Also, insider Vaughn B. Himes sold 10,000 shares of Seattle Genetics stock in a transaction on Thursday, November 30th. 29 funds opened positions while 69 raised stakes.

Cwm Llc, which manages about $1.90 billion and $2.12 billion US Long portfolio, upped its stake in Apache Corp (NYSE:APA) by 223,419 shares to 791,964 shares, valued at $36.27 million in 2017Q3, according to the filing. Mufg Americas reported 160 shares. Virtu Fin Ltd Liability Company holds 0.03% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN) Performing Well? Insiders have sold 138,378 shares of company stock worth $8,121,108 over the last quarter. Swiss Comml Bank has 0.02% invested in Seattle Genetics, Inc.

Seattle Genetics (NASDAQ:SGEN) last issued its quarterly earnings results on Thursday, October 26th. Tower Capital Limited Liability (Trc) stated it has 37 shares. Grandfield Dodd Limited Liability Company stated it has 11,086 shares or 0.07% of all its holdings. (NASDAQ:SGEN). Qs Lc owns 3,511 shares. We had modeled $42.5M in revenue for the full year.

Analysts await Myriad Genetics, Inc.

Latest analyst recommendations could offer little help to investors.

Other reports by Iphone Fresh

Discuss This Article